nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vincristine—sarcoma	0.827	1	CrCrCtD
Rescinnamine—ACE—forelimb zeugopod—sarcoma	0.0146	0.17	CbGeAlD
Rescinnamine—ACE—pulmonary artery—sarcoma	0.0109	0.127	CbGeAlD
Rescinnamine—ACE—forelimb—sarcoma	0.00734	0.0853	CbGeAlD
Rescinnamine—ACE—umbilical vein—sarcoma	0.00721	0.0839	CbGeAlD
Rescinnamine—ACE—hindlimb—sarcoma	0.0066	0.0768	CbGeAlD
Rescinnamine—ACE—arm—sarcoma	0.0063	0.0733	CbGeAlD
Rescinnamine—ACE—appendage—sarcoma	0.00566	0.0659	CbGeAlD
Rescinnamine—ACE—endothelium—sarcoma	0.00342	0.0397	CbGeAlD
Rescinnamine—Pigmentation disorder—Thiotepa—sarcoma	0.00335	0.0384	CcSEcCtD
Rescinnamine—Skin infection—Mitoxantrone—sarcoma	0.00319	0.0367	CcSEcCtD
Rescinnamine—SLC18A2—hematopoietic system—sarcoma	0.00246	0.0286	CbGeAlD
Rescinnamine—Pigmentation disorder—Etoposide—sarcoma	0.0024	0.0276	CcSEcCtD
Rescinnamine—ACE—embryo—sarcoma	0.00188	0.0219	CbGeAlD
Rescinnamine—Skin hyperpigmentation—Thiotepa—sarcoma	0.00188	0.0216	CcSEcCtD
Rescinnamine—SLC18A2—uterus—sarcoma	0.00186	0.0216	CbGeAlD
Rescinnamine—ACE—seminal vesicle—sarcoma	0.00177	0.0205	CbGeAlD
Rescinnamine—Hypothyroidism—Thiotepa—sarcoma	0.00174	0.02	CcSEcCtD
Rescinnamine—ACE—hematopoietic system—sarcoma	0.00168	0.0195	CbGeAlD
Rescinnamine—SLC18A2—tendon—sarcoma	0.00163	0.0189	CbGeAlD
Rescinnamine—ACE—connective tissue—sarcoma	0.00162	0.0188	CbGeAlD
Rescinnamine—ACE—smooth muscle tissue—sarcoma	0.00148	0.0172	CbGeAlD
Rescinnamine—Endocrine disorder—Thiotepa—sarcoma	0.00135	0.0155	CcSEcCtD
Rescinnamine—Pigmentation disorder—Epirubicin—sarcoma	0.00135	0.0155	CcSEcCtD
Rescinnamine—SLC18A2—testis—sarcoma	0.00135	0.0157	CbGeAlD
Rescinnamine—ACE—cardiac atrium—sarcoma	0.00127	0.0148	CbGeAlD
Rescinnamine—SLC18A2—liver—sarcoma	0.00127	0.0148	CbGeAlD
Rescinnamine—Pigmentation disorder—Doxorubicin—sarcoma	0.00125	0.0143	CcSEcCtD
Rescinnamine—Skin discolouration—Thiotepa—sarcoma	0.00124	0.0142	CcSEcCtD
Rescinnamine—ACE—lymphoid tissue—sarcoma	0.00118	0.0137	CbGeAlD
Rescinnamine—Bullous eruption—Epirubicin—sarcoma	0.00114	0.0131	CcSEcCtD
Rescinnamine—Dermatitis contact—Thiotepa—sarcoma	0.0011	0.0127	CcSEcCtD
Rescinnamine—ACE—bone marrow—sarcoma	0.00108	0.0125	CbGeAlD
Rescinnamine—Bullous eruption—Doxorubicin—sarcoma	0.00105	0.0121	CcSEcCtD
Rescinnamine—Tingling sensation—Etoposide—sarcoma	0.000998	0.0115	CcSEcCtD
Rescinnamine—SLC18A2—lymph node—sarcoma	0.000977	0.0114	CbGeAlD
Rescinnamine—ACE—testis—sarcoma	0.00092	0.0107	CbGeAlD
Rescinnamine—Skin discolouration—Etoposide—sarcoma	0.000888	0.0102	CcSEcCtD
Rescinnamine—ACE—liver—sarcoma	0.00087	0.0101	CbGeAlD
Rescinnamine—Skin hyperpigmentation—Epirubicin—sarcoma	0.000756	0.00868	CcSEcCtD
Rescinnamine—Psoriasis—Epirubicin—sarcoma	0.000716	0.00821	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Doxorubicin—sarcoma	0.0007	0.00803	CcSEcCtD
Rescinnamine—ACE—lymph node—sarcoma	0.000667	0.00775	CbGeAlD
Rescinnamine—Redness—Epirubicin—sarcoma	0.000666	0.00765	CcSEcCtD
Rescinnamine—Psoriasis—Doxorubicin—sarcoma	0.000662	0.0076	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Epirubicin—sarcoma	0.00066	0.00757	CcSEcCtD
Rescinnamine—Redness—Doxorubicin—sarcoma	0.000616	0.00708	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Doxorubicin—sarcoma	0.000611	0.00701	CcSEcCtD
Rescinnamine—Conjunctivitis—Thiotepa—sarcoma	0.000607	0.00697	CcSEcCtD
Rescinnamine—Herpes zoster—Epirubicin—sarcoma	0.000597	0.00686	CcSEcCtD
Rescinnamine—Gingivitis—Epirubicin—sarcoma	0.000573	0.00658	CcSEcCtD
Rescinnamine—Abscess—Epirubicin—sarcoma	0.000568	0.00653	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Vincristine—sarcoma	0.000567	0.00651	CcSEcCtD
Rescinnamine—Stinging—Epirubicin—sarcoma	0.000555	0.00637	CcSEcCtD
Rescinnamine—Herpes zoster—Doxorubicin—sarcoma	0.000553	0.00634	CcSEcCtD
Rescinnamine—Pharyngitis—Dactinomycin—sarcoma	0.000553	0.00634	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Vincristine—sarcoma	0.000546	0.00627	CcSEcCtD
Rescinnamine—Myocardial infarction—Vincristine—sarcoma	0.000543	0.00623	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Mitoxantrone—sarcoma	0.000532	0.00611	CcSEcCtD
Rescinnamine—Gingivitis—Doxorubicin—sarcoma	0.00053	0.00609	CcSEcCtD
Rescinnamine—Myocardial infarction—Mitoxantrone—sarcoma	0.000529	0.00607	CcSEcCtD
Rescinnamine—Abscess—Doxorubicin—sarcoma	0.000526	0.00604	CcSEcCtD
Rescinnamine—Conjunctivitis—Mitoxantrone—sarcoma	0.000525	0.00602	CcSEcCtD
Rescinnamine—Urinary tract infection—Mitoxantrone—sarcoma	0.000525	0.00602	CcSEcCtD
Rescinnamine—Stinging—Doxorubicin—sarcoma	0.000514	0.0059	CcSEcCtD
Rescinnamine—Sinusitis—Mitoxantrone—sarcoma	0.000506	0.00581	CcSEcCtD
Rescinnamine—Skin discolouration—Epirubicin—sarcoma	0.000498	0.00572	CcSEcCtD
Rescinnamine—Hypoaesthesia—Vincristine—sarcoma	0.000495	0.00568	CcSEcCtD
Rescinnamine—Cough increased—Epirubicin—sarcoma	0.000491	0.00564	CcSEcCtD
Rescinnamine—Erythema—Thiotepa—sarcoma	0.000488	0.00561	CcSEcCtD
Rescinnamine—Lacrimation increased—Epirubicin—sarcoma	0.000488	0.0056	CcSEcCtD
Rescinnamine—Rhinitis—Mitoxantrone—sarcoma	0.000486	0.00557	CcSEcCtD
Rescinnamine—Erythema—Dactinomycin—sarcoma	0.000485	0.00556	CcSEcCtD
Rescinnamine—Pharyngitis—Mitoxantrone—sarcoma	0.000481	0.00552	CcSEcCtD
Rescinnamine—Back pain—Thiotepa—sarcoma	0.000472	0.00542	CcSEcCtD
Rescinnamine—Skin discolouration—Doxorubicin—sarcoma	0.000461	0.00529	CcSEcCtD
Rescinnamine—Cough increased—Doxorubicin—sarcoma	0.000455	0.00522	CcSEcCtD
Rescinnamine—Lacrimation increased—Doxorubicin—sarcoma	0.000452	0.00518	CcSEcCtD
Rescinnamine—Vaginal inflammation—Epirubicin—sarcoma	0.00045	0.00516	CcSEcCtD
Rescinnamine—Dermatitis contact—Epirubicin—sarcoma	0.000444	0.0051	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Etoposide—sarcoma	0.000442	0.00508	CcSEcCtD
Rescinnamine—Myocardial infarction—Etoposide—sarcoma	0.00044	0.00505	CcSEcCtD
Rescinnamine—Cough—Thiotepa—sarcoma	0.000426	0.00489	CcSEcCtD
Rescinnamine—Vaginal infection—Epirubicin—sarcoma	0.000425	0.00487	CcSEcCtD
Rescinnamine—Erythema—Mitoxantrone—sarcoma	0.000422	0.00484	CcSEcCtD
Rescinnamine—Hypertension—Thiotepa—sarcoma	0.000422	0.00484	CcSEcCtD
Rescinnamine—Back pain—Vincristine—sarcoma	0.000419	0.00481	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—sarcoma	0.000416	0.00478	CcSEcCtD
Rescinnamine—Myalgia—Thiotepa—sarcoma	0.000416	0.00477	CcSEcCtD
Rescinnamine—Dysgeusia—Mitoxantrone—sarcoma	0.000413	0.00474	CcSEcCtD
Rescinnamine—Myalgia—Dactinomycin—sarcoma	0.000413	0.00474	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—sarcoma	0.000411	0.00472	CcSEcCtD
Rescinnamine—Back pain—Mitoxantrone—sarcoma	0.000408	0.00468	CcSEcCtD
Rescinnamine—Discomfort—Dactinomycin—sarcoma	0.000408	0.00468	CcSEcCtD
Rescinnamine—Hypoaesthesia—Etoposide—sarcoma	0.000401	0.0046	CcSEcCtD
Rescinnamine—Infection—Thiotepa—sarcoma	0.000396	0.00454	CcSEcCtD
Rescinnamine—Oedema—Dactinomycin—sarcoma	0.000396	0.00454	CcSEcCtD
Rescinnamine—Hypertonia—Epirubicin—sarcoma	0.000394	0.00453	CcSEcCtD
Rescinnamine—Infection—Dactinomycin—sarcoma	0.000393	0.00451	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—sarcoma	0.000393	0.00451	CcSEcCtD
Rescinnamine—Hypertension—Vincristine—sarcoma	0.000374	0.00429	CcSEcCtD
Rescinnamine—Myalgia—Vincristine—sarcoma	0.000369	0.00423	CcSEcCtD
Rescinnamine—Cough—Mitoxantrone—sarcoma	0.000368	0.00422	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—sarcoma	0.000365	0.00419	CcSEcCtD
Rescinnamine—Hypertension—Mitoxantrone—sarcoma	0.000364	0.00418	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000363	0.00417	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00036	0.00414	CcSEcCtD
Rescinnamine—Myalgia—Mitoxantrone—sarcoma	0.000359	0.00412	CcSEcCtD
Rescinnamine—Paraesthesia—Thiotepa—sarcoma	0.000358	0.00411	CcSEcCtD
Rescinnamine—Discomfort—Mitoxantrone—sarcoma	0.000355	0.00407	CcSEcCtD
Rescinnamine—Oedema—Vincristine—sarcoma	0.000353	0.00406	CcSEcCtD
Rescinnamine—Infection—Vincristine—sarcoma	0.000351	0.00403	CcSEcCtD
Rescinnamine—Oedema—Mitoxantrone—sarcoma	0.000344	0.00395	CcSEcCtD
Rescinnamine—Dysgeusia—Etoposide—sarcoma	0.000343	0.00394	CcSEcCtD
Rescinnamine—Infection—Mitoxantrone—sarcoma	0.000342	0.00392	CcSEcCtD
Rescinnamine—Dermatitis bullous—Epirubicin—sarcoma	0.000342	0.00392	CcSEcCtD
Rescinnamine—Pain—Thiotepa—sarcoma	0.000341	0.00391	CcSEcCtD
Rescinnamine—Constipation—Thiotepa—sarcoma	0.000341	0.00391	CcSEcCtD
Rescinnamine—Back pain—Etoposide—sarcoma	0.000339	0.00389	CcSEcCtD
Rescinnamine—Pain—Dactinomycin—sarcoma	0.000338	0.00388	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Thiotepa—sarcoma	0.000326	0.00374	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000323	0.00371	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000322	0.0037	CcSEcCtD
Rescinnamine—Insomnia—Vincristine—sarcoma	0.00032	0.00367	CcSEcCtD
Rescinnamine—Paraesthesia—Vincristine—sarcoma	0.000317	0.00364	CcSEcCtD
Rescinnamine—Urticaria—Thiotepa—sarcoma	0.000317	0.00363	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—sarcoma	0.000316	0.00363	CcSEcCtD
Rescinnamine—Abdominal pain—Thiotepa—sarcoma	0.000315	0.00362	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000314	0.0036	CcSEcCtD
Rescinnamine—Abdominal pain—Dactinomycin—sarcoma	0.000313	0.00359	CcSEcCtD
Rescinnamine—Paraesthesia—Mitoxantrone—sarcoma	0.000309	0.00355	CcSEcCtD
Rescinnamine—Cough—Etoposide—sarcoma	0.000306	0.00351	CcSEcCtD
Rescinnamine—Hypertension—Etoposide—sarcoma	0.000303	0.00348	CcSEcCtD
Rescinnamine—Pain—Vincristine—sarcoma	0.000302	0.00347	CcSEcCtD
Rescinnamine—Constipation—Vincristine—sarcoma	0.000302	0.00347	CcSEcCtD
Rescinnamine—Discomfort—Etoposide—sarcoma	0.000295	0.00339	CcSEcCtD
Rescinnamine—Constipation—Mitoxantrone—sarcoma	0.000294	0.00338	CcSEcCtD
Rescinnamine—Pain—Mitoxantrone—sarcoma	0.000294	0.00338	CcSEcCtD
Rescinnamine—Hypersensitivity—Thiotepa—sarcoma	0.000294	0.00337	CcSEcCtD
Rescinnamine—Hypersensitivity—Dactinomycin—sarcoma	0.000291	0.00335	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vincristine—sarcoma	0.000289	0.00332	CcSEcCtD
Rescinnamine—Gastritis—Epirubicin—sarcoma	0.000289	0.00332	CcSEcCtD
Rescinnamine—Infection—Etoposide—sarcoma	0.000284	0.00326	CcSEcCtD
Rescinnamine—Influenza—Epirubicin—sarcoma	0.000282	0.00324	CcSEcCtD
Rescinnamine—Pruritus—Thiotepa—sarcoma	0.000282	0.00324	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000281	0.00323	CcSEcCtD
Rescinnamine—Abdominal pain—Vincristine—sarcoma	0.000279	0.00321	CcSEcCtD
Rescinnamine—Angina pectoris—Epirubicin—sarcoma	0.000275	0.00316	CcSEcCtD
Rescinnamine—Urticaria—Mitoxantrone—sarcoma	0.000273	0.00314	CcSEcCtD
Rescinnamine—Abdominal pain—Mitoxantrone—sarcoma	0.000272	0.00312	CcSEcCtD
Rescinnamine—Bronchitis—Epirubicin—sarcoma	0.000271	0.00312	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—sarcoma	0.000267	0.00307	CcSEcCtD
Rescinnamine—Dizziness—Thiotepa—sarcoma	0.000264	0.00303	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—sarcoma	0.000261	0.003	CcSEcCtD
Rescinnamine—Hypersensitivity—Vincristine—sarcoma	0.00026	0.00299	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Epirubicin—sarcoma	0.000258	0.00296	CcSEcCtD
Rescinnamine—Paraesthesia—Etoposide—sarcoma	0.000257	0.00295	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—sarcoma	0.000254	0.00292	CcSEcCtD
Rescinnamine—Hypersensitivity—Mitoxantrone—sarcoma	0.000254	0.00291	CcSEcCtD
Rescinnamine—Rash—Thiotepa—sarcoma	0.000251	0.00288	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—sarcoma	0.000251	0.00288	CcSEcCtD
Rescinnamine—Dermatitis—Thiotepa—sarcoma	0.000251	0.00288	CcSEcCtD
Rescinnamine—Headache—Thiotepa—sarcoma	0.00025	0.00287	CcSEcCtD
Rescinnamine—Rash—Dactinomycin—sarcoma	0.000249	0.00286	CcSEcCtD
Rescinnamine—Pain—Etoposide—sarcoma	0.000245	0.00281	CcSEcCtD
Rescinnamine—Constipation—Etoposide—sarcoma	0.000245	0.00281	CcSEcCtD
Rescinnamine—Conjunctivitis—Epirubicin—sarcoma	0.000245	0.00281	CcSEcCtD
Rescinnamine—Urinary tract infection—Epirubicin—sarcoma	0.000245	0.00281	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—sarcoma	0.000238	0.00274	CcSEcCtD
Rescinnamine—Nausea—Thiotepa—sarcoma	0.000237	0.00272	CcSEcCtD
Rescinnamine—Sinusitis—Epirubicin—sarcoma	0.000236	0.00271	CcSEcCtD
Rescinnamine—Nausea—Dactinomycin—sarcoma	0.000235	0.0027	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Etoposide—sarcoma	0.000234	0.00269	CcSEcCtD
Rescinnamine—Dizziness—Vincristine—sarcoma	0.000234	0.00268	CcSEcCtD
Rescinnamine—Urticaria—Etoposide—sarcoma	0.000227	0.00261	CcSEcCtD
Rescinnamine—Rhinitis—Epirubicin—sarcoma	0.000226	0.0026	CcSEcCtD
Rescinnamine—Abdominal pain—Etoposide—sarcoma	0.000226	0.0026	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—sarcoma	0.000226	0.0026	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—sarcoma	0.000226	0.0026	CcSEcCtD
Rescinnamine—Hypoaesthesia—Epirubicin—sarcoma	0.000225	0.00258	CcSEcCtD
Rescinnamine—Pharyngitis—Epirubicin—sarcoma	0.000224	0.00257	CcSEcCtD
Rescinnamine—Rash—Vincristine—sarcoma	0.000223	0.00256	CcSEcCtD
Rescinnamine—Dermatitis—Vincristine—sarcoma	0.000223	0.00256	CcSEcCtD
Rescinnamine—Headache—Vincristine—sarcoma	0.000221	0.00254	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—sarcoma	0.000218	0.00251	CcSEcCtD
Rescinnamine—Rash—Mitoxantrone—sarcoma	0.000217	0.00249	CcSEcCtD
Rescinnamine—Dermatitis—Mitoxantrone—sarcoma	0.000217	0.00249	CcSEcCtD
Rescinnamine—Headache—Mitoxantrone—sarcoma	0.000216	0.00247	CcSEcCtD
Rescinnamine—Hypersensitivity—Etoposide—sarcoma	0.000211	0.00242	CcSEcCtD
Rescinnamine—Nausea—Vincristine—sarcoma	0.00021	0.00241	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—sarcoma	0.00021	0.0024	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—sarcoma	0.000208	0.00239	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—sarcoma	0.000207	0.00238	CcSEcCtD
Rescinnamine—Nausea—Mitoxantrone—sarcoma	0.000204	0.00235	CcSEcCtD
Rescinnamine—Pruritus—Etoposide—sarcoma	0.000203	0.00232	CcSEcCtD
Rescinnamine—Erythema—Epirubicin—sarcoma	0.000197	0.00226	CcSEcCtD
Rescinnamine—Dysgeusia—Epirubicin—sarcoma	0.000193	0.00221	CcSEcCtD
Rescinnamine—Back pain—Epirubicin—sarcoma	0.00019	0.00218	CcSEcCtD
Rescinnamine—Dizziness—Etoposide—sarcoma	0.000189	0.00217	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—sarcoma	0.000182	0.00209	CcSEcCtD
Rescinnamine—Rash—Etoposide—sarcoma	0.00018	0.00207	CcSEcCtD
Rescinnamine—Dermatitis—Etoposide—sarcoma	0.00018	0.00207	CcSEcCtD
Rescinnamine—Headache—Etoposide—sarcoma	0.000179	0.00206	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—sarcoma	0.000178	0.00204	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—sarcoma	0.000176	0.00202	CcSEcCtD
Rescinnamine—Cough—Epirubicin—sarcoma	0.000172	0.00197	CcSEcCtD
Rescinnamine—Nausea—Etoposide—sarcoma	0.00017	0.00195	CcSEcCtD
Rescinnamine—Hypertension—Epirubicin—sarcoma	0.00017	0.00195	CcSEcCtD
Rescinnamine—Myalgia—Epirubicin—sarcoma	0.000167	0.00192	CcSEcCtD
Rescinnamine—Discomfort—Epirubicin—sarcoma	0.000165	0.0019	CcSEcCtD
Rescinnamine—Oedema—Epirubicin—sarcoma	0.00016	0.00184	CcSEcCtD
Rescinnamine—Infection—Epirubicin—sarcoma	0.000159	0.00183	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—sarcoma	0.000159	0.00182	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—sarcoma	0.000157	0.0018	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—sarcoma	0.000155	0.00178	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—sarcoma	0.000153	0.00176	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—sarcoma	0.000148	0.0017	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—sarcoma	0.000148	0.00169	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000146	0.00168	CcSEcCtD
Rescinnamine—Insomnia—Epirubicin—sarcoma	0.000145	0.00167	CcSEcCtD
Rescinnamine—Paraesthesia—Epirubicin—sarcoma	0.000144	0.00165	CcSEcCtD
Rescinnamine—Pain—Epirubicin—sarcoma	0.000137	0.00158	CcSEcCtD
Rescinnamine—Constipation—Epirubicin—sarcoma	0.000137	0.00158	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000135	0.00155	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—sarcoma	0.000134	0.00154	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—sarcoma	0.000133	0.00153	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Epirubicin—sarcoma	0.000131	0.00151	CcSEcCtD
Rescinnamine—Urticaria—Epirubicin—sarcoma	0.000127	0.00146	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—sarcoma	0.000127	0.00146	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—sarcoma	0.000127	0.00146	CcSEcCtD
Rescinnamine—Abdominal pain—Epirubicin—sarcoma	0.000127	0.00146	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000121	0.00139	CcSEcCtD
Rescinnamine—Hypersensitivity—Epirubicin—sarcoma	0.000118	0.00136	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—sarcoma	0.000118	0.00135	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—sarcoma	0.000117	0.00135	CcSEcCtD
Rescinnamine—Pruritus—Epirubicin—sarcoma	0.000114	0.0013	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—sarcoma	0.000109	0.00126	CcSEcCtD
Rescinnamine—Dizziness—Epirubicin—sarcoma	0.000106	0.00122	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—sarcoma	0.000105	0.00121	CcSEcCtD
Rescinnamine—Rash—Epirubicin—sarcoma	0.000101	0.00116	CcSEcCtD
Rescinnamine—Dermatitis—Epirubicin—sarcoma	0.000101	0.00116	CcSEcCtD
Rescinnamine—Headache—Epirubicin—sarcoma	0.000101	0.00115	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—sarcoma	9.82e-05	0.00113	CcSEcCtD
Rescinnamine—Nausea—Epirubicin—sarcoma	9.53e-05	0.00109	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—sarcoma	9.36e-05	0.00107	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—sarcoma	9.35e-05	0.00107	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—sarcoma	9.3e-05	0.00107	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—sarcoma	8.82e-05	0.00101	CcSEcCtD
